Your Trusted Partner for Pharmacovigilance Support in Norway
Norway represents a mature and highly regulated pharmaceutical market within the European Economic Area (EEA), offering strong opportunities for companies aiming to expand across Europe. However, market access and lifecycle compliance in Norway are tightly governed by EU pharmacovigilance legislation, local regulatory expectations, and stringent safety monitoring requirements.
Operating successfully in Norway requires more than global systems; it demands precise alignment with EEA pharmacovigilance frameworks, local regulatory communication readiness, and inspection-ready safety infrastructure.
At DDReg, we deliver end-to-end pharmacovigilance services in Norway, enabling pharmaceutical companies to maintain compliance, ensure patient safety, and meet both EU and country-specific obligations.
Pharmacovigilance Framework in Norway
Pharmacovigilance in Norway is regulated by the Norwegian Medicines Agency (Statens legemiddelverk) under the Ministry of Health and Care Services.
As a member of the EEA, Norway adopts EU pharmacovigilance legislation, including centralized and decentralized procedures, making compliance with EU frameworks essential for all Marketing Authorization Holders (MAHs).
Normative Framework Governing Pharmacovigilance in Norway
Pharmacovigilance obligations in Norway are defined through a combination of national legislation and EU-aligned regulatory frameworks:
- Norwegian Medicines Act (Legemiddelloven) – Establishes the national legal framework aligned with EU directives
- Directive 2001/83/EC – Governs medicinal products for human use across the EU/EEA
- Regulation (EC) No 726/2004 – Defines centralized authorization procedures and EMA oversight
- EU Good Pharmacovigilance Practices (GVP) – Core operational framework for pharmacovigilance activities
- Norwegian Medicines Agency Guidelines – Provide country-specific submission requirements, reporting timelines, and compliance expectations
This integrated framework requires strict adherence to both EU-wide and local regulatory expectations.
QPPV and Local Pharmacovigilance Requirements in Norway
-
Qualified Person for Pharmacovigilance (QPPV)
- Mandatory for all MAHs
- Must reside within the EU/EEA
- Responsible for:
- Establishing and maintaining the pharmacovigilance system
- Oversight of product safety profiles
- Acting as the single point of contact for regulatory authorities (24/7 availability)
-
Local Pharmacovigilance Contact in Norway
- Not always mandatory, but commonly designated
- Facilitates:
- Communication with the Norwegian Medicines Agency
- Handling adverse event reporting in Norwegian
- Local regulatory coordination
-
Pharmacovigilance System Master File (PSMF)
- MAHs must maintain a PSMF describing their pharmacovigilance system
- Must be readily available for inspection
- Must align with EU GVP Module II requirements
DDReg provides comprehensive drug safety services in Norway, ensuring full compliance with EU GVP and Norwegian regulatory expectations.
-
Individual Case Safety Report (ICSR) Management
-
Aggregate Reporting & Safety Writing
-
Signal Detection & Risk Management
-
QPPV Support & Local PV Compliance
-
Literature Screening & Safety Intelligence
-
Pharmacovigilance Consulting Services in Norway
Why Choose DDReg as Your Pharmacovigilance Company in Norway?
Deep understanding of EU pharmacovigilance legislation and Norwegian regulatory nuances.
From clinical development to post-marketing surveillance.
Designed for EMA and national authority audits.
Aligning EU QPPV oversight with local compliance requirements. .
Advanced safety databases and automation for accuracy and efficiency.
Global Reach Explorer
Find Your Solution
Our Pharmacovigilance (PV) Services Expertise
ICSR Case Processing and Submission
Our advanced Individual Case Safety Report (ICSR) Pharmacovigilance Services are dedicated to ensuring patient safety through precise case handling....
Literature Monitoring
DDReg’s Literature Monitoring Services offer advanced pharmacovigilance literature screening for drug safety. We help Marketing...
Risk Management
Our expert risk management solutions ensure patient safety by proactively addressing potential hazards in pharmaceutical...
Audit and Compliance
Our specialized services ensure that pharmacovigilance systems across the drug development pipeline meet strict regulatory...
Pharmacovigilance Signal Management Services
DDReg’s specialized pharmacovigilance services ensure that potential adverse events are identified and addressed promptly...
QPPV Services
DDReg’s expert team provides comprehensive QPPV services designed to strengthen your pharmacovigilance system. We ensure that...
